# Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

> **NCT04952506** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 25 (actual)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** CKD-349 F1 Tab.
- **DRUG:** CKD-349 F2 Tab.
- **DRUG:** D113 Tab.

## Key facts

- **NCT ID:** NCT04952506
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-19
- **Primary completion:** 2021-07-29
- **Final completion:** 2021-08-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04952506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04952506, "Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04952506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*